Chronic heart failure with maintenance of systolic function of the left ventricle of the heart, as a characteristic stage of cardiovascular hypertension of arterial hypertension
Abstract
The aim of the study was a comparative analysis of studies on chronic heart failure with maintenance of systolic function of the left ventricle.
The evolution of clinical and pathogenetic events leading to the development of chronic heart failure, starting with the risk factor, was first described in E. Brownwald's theory of the "Continuum of the Cardiovascular" (CDC). Arterial hypertension and hypertonic changes of the heart, which play a key role in the process of developing along the "cardiovascular" continuum, go through several stages of this process, eventually leading to the development of irreversible changes. In chronic heart failure with maintenance of systolic function of the left ventricle, the process begins conditionally in the periphery (eg, arterial hypertension) and then is accompanied by a pathological process in the heart (hypertrophy, ischemia, arrhythmia). The study of these issues is relevant for fundamental and practical cardiology, as their solution will allow the development of recommendations aimed at improving the quality of examination of patients with AH, optimizing treatment to prevent complications and the development of dynamic monitoring.
References
Braunwald Z.F. Heart Disease: A Textbook Of Cardiovascular Medicine / Z.F.Braunwald – 11 ed. – 2018. – 5174 p.
Горбунов, В.В. Иммунологические наруше-ния и дисфункция эндотелия как предикторы развития гипертрофии левого желудочка у больных гипертонической болезнью / В.В.Гор-бунов, С.А.Лукьянов, А.В. Говорин [и др.] // Забайкальский медицинский вестник. Чита: – 2011. № 2, – c. 104–111.
Brouwers, F. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND / Frank P Brouwers, Rudolf A de Boer, Pim van der Harst [et al.] // Eur. Heart J. – 2013. 34(19), – p. 1424–1431.
Banerjee, P. Diastolic heart failure. Paroxysmal or chronic? / Prithwish Banerjee, Andrew L Clark, Nikolay Nikitin, [et al.] // Eur. J. Heart Fail. – 2004. Jun; 6(4), – p. 427.
McMurray, J. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure / John J V McMurray, Stamatis Adamopoulos Stef-an D Anker [et al.] // Eur. Heart J. – 2012. Jul; 33(14), – p. 1787–1847.
Maeder, M. Kaye, D. Heart failure with normal left ventricular ejection fraction // J. Am. Coll. Cardiol. – 2009. 53(11), – p. 905–918.
Zile, M. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Pre-served Ejection Fraction Study (I-Preserve) trial / Michael R Zile, William H Gaasch, Inder S Anand [et al.] // Circulation. – 2010. Mar; 121(12), – p. 1393–1405.
Мареев, В.Ю. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лече-нию ХСН (четвертый пересмотр) / В.Ю.Мареев, Ф.Т.Агеев, Г.П.Арутюнов [и др.] // Журнал сердечная недостаточность, – Москва: – 2013. – т.14, № 7, – с. 379–472.
McKelvie, G.W. Moe, J.A. Ezekowitz // Can. J. Cardiol. – 2013. 29, – р. 168–181.
Ferrari, R. Heart failure with preserved ejec-tion fraction: uncertainties and dilemmas / Roberto Ferrari, Michael Böhm, John G F Cleland [et al.] // Eur. J. of Heart Failure. – 2015. Jul; 17(7). – p. 665–671.
Зобнина, М.П. Ретроспективная оценка про-гноза выживаемости больных эссенциальной артериальной гипертензией в зависимости от исходных особенностей ремоделирования ле-вого желудочка: / автореферат диссертации кандидата медицинских наук )/ – Санкт-Петербург, 2013. – 22 с.
Свеклина, Т.С., Таланцева, М.С., Барсуков, А.В. Метаболический синдром и воспаление: актуальные вопросы патогенеза // – Москва:
Berry, C. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) / C. Berry, R. Doughty, C. Granger [et al.] // Eur. Heart J. – 2012. 33(14), – p. 1750–1757.
Carlsen, C. Prevalence and prognosis of heart failure with preserved ejection fraction and elevat-ed N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study / Christian Malchau Carlsen 1, Morten Bay, Vibeke Kirk [et al.] // Eur. J. Heart Fail. – 2012. – Mar; 14(3), – p. 240–247.
Zipes, D. ACC/AHA/ESC 2006 guidelins for management of patients with ventricular arrhyth-mias and the prevention of sudden cardiac death–executive summary / Douglas P Zipes, A John Camm, Martin Borggrefe [et al.] // Eur Heart J. – 2006. Sep; 27(17), – p. 2099-2140.
Zile, M., Baicu, C., Gaasch, W. Diastolic heart failure – abnormalities in active relaxation and passive stiffness of the left ventricle // N Engl J Med. – 2004. 350(19), – p. 1953–1959.
Zucker, I.. L. Xiao, L., Haack, K. The central renin–angiotensin system and sympathetic nerve activity in chronic heart failure // Clin. Sci. (Lond). – 2014. May; 126(10), – p. 695–706.
Keywords
hypertonic changes of the heart
arterial hypertension
heart problem Сердечно-сосудистый континуум
гипертонические изменения сердца
артериальная гипертензия
проблема с сердцем “Ürək-damar” kontinuumu
ürəyin hipertonik dəyişməsi
arterial hipertenziya
ürək çatışmazlığı
Most read articles by the same author(s)
- Gurbanova X.I., Alimetov S.N., Ibrahimova S.S., Muradova S.R., PATHOGENETIC ROLE OF CYTOKINE ACTIVATION AND DISORDERS OF THE HEMOSTASIS SYSTEM IN THE DEVELOPMENT OF HEART FAILURE IN PATIENTS WITH ARTERIAL HYPERTENSION , Journal of Theoretical, Clinical and Experimental Morphology: Vol. 4 No. 1-2 (2022): JOURNAL OF THEORETICAL CLINICAL AND EXPERIMENTAL MORPHOLOGY